MAT2A was found as a synthetic lethal target in methylthioadenosine phosphorylase (MTAP)‐deficient cancer cells, and the mechanism involves SAM‐utilizing protein arginine methyltransferase 5 (PRMT5). This evidence concerns the gene PRMT5 and cancer.